aluates Reports

$ 0.0

Automative

Ophthalmology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-0D2968

COVID 19 Impact on Ophthalmology Drugs Market Global Research Reports 2020 2021

BUY CHAPTERS

Ophthalmology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-0D2968

Report

September 2024

Pages:121

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Aerie Pharmaceuticals

Pfizer Inc

Valeant

Bayer

Genentech Inc

Novartis

Regeneron

Takeda

Santen Pharmaceutical

AbbVie

Ophthalmology Drugs - Market Size

The global market for Ophthalmology Drugs was estimated to be worth US$ 31240 million in 2023 and is forecast to a readjusted size of US$ 53540 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030

Ophthalmology Drugs - Market

Drugs for ophthalmology, which are used to treat eye conditions and eye diseases such as glaucoma, conjunctivitis and others.

The Ophthalmology Drugs market refers to the pharmaceuticals and medications used for the treatment of various eye conditions and diseases, including glaucoma, age-related macular degeneration, dry eye syndrome, and ocular infections. This market encompasses therapeutic areas such as ophthalmic solutions, ointments, and oral medications. The Ophthalmology Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of eye disorders, the aging population, and technological advancements in the field of ophthalmology. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of eye disorders and improving healthcare infrastructure.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ophthalmology Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ophthalmology Drugs by region & country, by Type, and by Application.

The Ophthalmology Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmology Drugs.

Market Segmentation

Scope of Ophthalmology Drugs - Market Report

Report Metric	Details
Report Name	Ophthalmology Drugs - Market
Forecasted market size in 2030	US$ 53540 million
CAGR	8.0%
Forecasted years	2024 - 2030
Segment by Type:	Gels Eye Solutions Capsules & Tablets Eye Drops Ointments
Segment by Application	Hospital Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Aerie Pharmaceuticals, Pfizer, Valeant, Bayer, Genentech, Novartis, Regeneron, Takeda, Santen Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ophthalmology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ophthalmology Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ophthalmology Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Ophthalmology Drugs - Market size in 2030?

Ans: The Ophthalmology Drugs - Market size in 2030 will be US$ 53540 million.

Who are the main players in the Ophthalmology Drugs - Market report?

Ans: The main players in the Ophthalmology Drugs - Market are AbbVie, Aerie Pharmaceuticals, Pfizer, Valeant, Bayer, Genentech, Novartis, Regeneron, Takeda, Santen Pharmaceutical

What are the Application segmentation covered in the Ophthalmology Drugs - Market report?

Ans: The Applications covered in the Ophthalmology Drugs - Market report are Hospital, Retail Pharmacy

What are the Type segmentation covered in the Ophthalmology Drugs - Market report?

Ans: The Types covered in the Ophthalmology Drugs - Market report are Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments

Recommended Reports

Ophthalmology Drug Therapy

Ophthalmic Delivery Systems

Ophthalmology Devices & Diagnosis

1 Market Overview

1.1 Ophthalmology Drugs Product Introduction

1.2 Global Ophthalmology Drugs Market Size Forecast

1.2.1 Global Ophthalmology Drugs Sales Value (2019-2030)

1.2.2 Global Ophthalmology Drugs Sales Volume (2019-2030)

1.2.3 Global Ophthalmology Drugs Sales Price (2019-2030)

1.3 Ophthalmology Drugs Market Trends & Drivers

1.3.1 Ophthalmology Drugs Industry Trends

1.3.2 Ophthalmology Drugs Market Drivers & Opportunity

1.3.3 Ophthalmology Drugs Market Challenges

1.3.4 Ophthalmology Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Ophthalmology Drugs Players Revenue Ranking (2023)

2.2 Global Ophthalmology Drugs Revenue by Company (2019-2024)

2.3 Global Ophthalmology Drugs Players Sales Volume Ranking (2023)

2.4 Global Ophthalmology Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Ophthalmology Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Ophthalmology Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Ophthalmology Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Ophthalmology Drugs

2.9 Ophthalmology Drugs Market Competitive Analysis

2.9.1 Ophthalmology Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Ophthalmology Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Gels

3.1.2 Eye Solutions

3.1.3 Capsules & Tablets

3.1.4 Eye Drops

3.1.5 Ointments

3.2 Global Ophthalmology Drugs Sales Value by Type

3.2.1 Global Ophthalmology Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Ophthalmology Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Ophthalmology Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Ophthalmology Drugs Sales Volume by Type

3.3.1 Global Ophthalmology Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Ophthalmology Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Ophthalmology Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Ophthalmology Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Retail Pharmacy

4.2 Global Ophthalmology Drugs Sales Value by Application

4.2.1 Global Ophthalmology Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Ophthalmology Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Ophthalmology Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Ophthalmology Drugs Sales Volume by Application

4.3.1 Global Ophthalmology Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Ophthalmology Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Ophthalmology Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Ophthalmology Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Ophthalmology Drugs Sales Value by Region

5.1.1 Global Ophthalmology Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Ophthalmology Drugs Sales Value by Region (2019-2024)

5.1.3 Global Ophthalmology Drugs Sales Value by Region (2025-2030)

5.1.4 Global Ophthalmology Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Ophthalmology Drugs Sales Volume by Region

5.2.1 Global Ophthalmology Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Ophthalmology Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Ophthalmology Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Ophthalmology Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Ophthalmology Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Ophthalmology Drugs Sales Value, 2019-2030

5.4.2 North America Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Ophthalmology Drugs Sales Value, 2019-2030

5.5.2 Europe Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Ophthalmology Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Ophthalmology Drugs Sales Value, 2019-2030

5.7.2 South America Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Ophthalmology Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Ophthalmology Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Ophthalmology Drugs Sales Value

6.2.1 Key Countries/Regions Ophthalmology Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Ophthalmology Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Ophthalmology Drugs Sales Value, 2019-2030

6.3.2 United States Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Ophthalmology Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Ophthalmology Drugs Sales Value, 2019-2030

6.4.2 Europe Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Ophthalmology Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Ophthalmology Drugs Sales Value, 2019-2030

6.5.2 China Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Ophthalmology Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Ophthalmology Drugs Sales Value, 2019-2030

6.6.2 Japan Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Ophthalmology Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Ophthalmology Drugs Sales Value, 2019-2030

6.7.2 South Korea Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Ophthalmology Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Ophthalmology Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Ophthalmology Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Ophthalmology Drugs Sales Value, 2019-2030

6.9.2 India Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Ophthalmology Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AbbVie

7.1.1 AbbVie Company Information

7.1.2 AbbVie Introduction and Business Overview

7.1.3 AbbVie Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 AbbVie Ophthalmology Drugs Product Offerings

7.1.5 AbbVie Recent Development

7.2 Aerie Pharmaceuticals

7.2.1 Aerie Pharmaceuticals Company Information

7.2.2 Aerie Pharmaceuticals Introduction and Business Overview

7.2.3 Aerie Pharmaceuticals Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Aerie Pharmaceuticals Ophthalmology Drugs Product Offerings

7.2.5 Aerie Pharmaceuticals Recent Development

7.3 Pfizer

7.3.1 Pfizer Company Information

7.3.2 Pfizer Introduction and Business Overview

7.3.3 Pfizer Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Pfizer Ophthalmology Drugs Product Offerings

7.3.5 Pfizer Recent Development

7.4 Valeant

7.4.1 Valeant Company Information

7.4.2 Valeant Introduction and Business Overview

7.4.3 Valeant Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Valeant Ophthalmology Drugs Product Offerings

7.4.5 Valeant Recent Development

7.5 Bayer

7.5.1 Bayer Company Information

7.5.2 Bayer Introduction and Business Overview

7.5.3 Bayer Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Bayer Ophthalmology Drugs Product Offerings

7.5.5 Bayer Recent Development

7.6 Genentech

7.6.1 Genentech Company Information

7.6.2 Genentech Introduction and Business Overview

7.6.3 Genentech Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Genentech Ophthalmology Drugs Product Offerings

7.6.5 Genentech Recent Development

7.7 Novartis

7.7.1 Novartis Company Information

7.7.2 Novartis Introduction and Business Overview

7.7.3 Novartis Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Novartis Ophthalmology Drugs Product Offerings

7.7.5 Novartis Recent Development

7.8 Regeneron

7.8.1 Regeneron Company Information

7.8.2 Regeneron Introduction and Business Overview

7.8.3 Regeneron Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Regeneron Ophthalmology Drugs Product Offerings

7.8.5 Regeneron Recent Development

7.9 Takeda

7.9.1 Takeda Company Information

7.9.2 Takeda Introduction and Business Overview

7.9.3 Takeda Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Takeda Ophthalmology Drugs Product Offerings

7.9.5 Takeda Recent Development

7.10 Santen Pharmaceutical

7.10.1 Santen Pharmaceutical Company Information

7.10.2 Santen Pharmaceutical Introduction and Business Overview

7.10.3 Santen Pharmaceutical Ophthalmology Drugs Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Santen Pharmaceutical Ophthalmology Drugs Product Offerings

7.10.5 Santen Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Ophthalmology Drugs Industrial Chain

8.2 Ophthalmology Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Ophthalmology Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Ophthalmology Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Aerie Pharmaceuticals

Pfizer Inc

Valeant

Bayer

Genentech Inc

Novartis

Regeneron

Takeda

Santen Pharmaceutical

AbbVie

List of Tables

Table 1. Ophthalmology Drugs Market Trends

Table 2. Ophthalmology Drugs Market Drivers & Opportunity

Table 3. Ophthalmology Drugs Market Challenges

Table 4. Ophthalmology Drugs Market Restraints

Table 5. Global Ophthalmology Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Ophthalmology Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Ophthalmology Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Ophthalmology Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Ophthalmology Drugs Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Ophthalmology Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Ophthalmology Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Ophthalmology Drugs

Table 13. Global Ophthalmology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Ophthalmology Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Ophthalmology Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Ophthalmology Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Ophthalmology Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Ophthalmology Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Ophthalmology Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Ophthalmology Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Ophthalmology Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Ophthalmology Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Ophthalmology Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Ophthalmology Drugs Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Ophthalmology Drugs Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Ophthalmology Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Ophthalmology Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Ophthalmology Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Ophthalmology Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Ophthalmology Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Ophthalmology Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Ophthalmology Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Ophthalmology Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Ophthalmology Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Ophthalmology Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Ophthalmology Drugs Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Ophthalmology Drugs Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Ophthalmology Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Ophthalmology Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Ophthalmology Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Ophthalmology Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Ophthalmology Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Ophthalmology Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Ophthalmology Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Ophthalmology Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Ophthalmology Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Ophthalmology Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Ophthalmology Drugs Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Ophthalmology Drugs Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Ophthalmology Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Ophthalmology Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Ophthalmology Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Ophthalmology Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Ophthalmology Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. AbbVie Company Information

Table 58. AbbVie Introduction and Business Overview

Table 59. AbbVie Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. AbbVie Ophthalmology Drugs Product Offerings

Table 61. AbbVie Recent Development

Table 62. Aerie Pharmaceuticals Company Information

Table 63. Aerie Pharmaceuticals Introduction and Business Overview

Table 64. Aerie Pharmaceuticals Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Aerie Pharmaceuticals Ophthalmology Drugs Product Offerings

Table 66. Aerie Pharmaceuticals Recent Development

Table 67. Pfizer Company Information

Table 68. Pfizer Introduction and Business Overview

Table 69. Pfizer Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Pfizer Ophthalmology Drugs Product Offerings

Table 71. Pfizer Recent Development

Table 72. Valeant Company Information

Table 73. Valeant Introduction and Business Overview

Table 74. Valeant Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Valeant Ophthalmology Drugs Product Offerings

Table 76. Valeant Recent Development

Table 77. Bayer Company Information

Table 78. Bayer Introduction and Business Overview

Table 79. Bayer Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Bayer Ophthalmology Drugs Product Offerings

Table 81. Bayer Recent Development

Table 82. Genentech Company Information

Table 83. Genentech Introduction and Business Overview

Table 84. Genentech Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Genentech Ophthalmology Drugs Product Offerings

Table 86. Genentech Recent Development

Table 87. Novartis Company Information

Table 88. Novartis Introduction and Business Overview

Table 89. Novartis Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Novartis Ophthalmology Drugs Product Offerings

Table 91. Novartis Recent Development

Table 92. Regeneron Company Information

Table 93. Regeneron Introduction and Business Overview

Table 94. Regeneron Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Regeneron Ophthalmology Drugs Product Offerings

Table 96. Regeneron Recent Development

Table 97. Takeda Company Information

Table 98. Takeda Introduction and Business Overview

Table 99. Takeda Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Takeda Ophthalmology Drugs Product Offerings

Table 101. Takeda Recent Development

Table 102. Santen Pharmaceutical Company Information

Table 103. Santen Pharmaceutical Introduction and Business Overview

Table 104. Santen Pharmaceutical Ophthalmology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Santen Pharmaceutical Ophthalmology Drugs Product Offerings

Table 106. Santen Pharmaceutical Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Ophthalmology Drugs Downstream Customers

Table 110. Ophthalmology Drugs Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Ophthalmology Drugs Product Picture

Figure 2. Global Ophthalmology Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Ophthalmology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Ophthalmology Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Ophthalmology Drugs Sales Price (2019-2030) & (USD/Unit)

Figure 6. Ophthalmology Drugs Report Years Considered

Figure 7. Global Ophthalmology Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Ophthalmology Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ophthalmology Drugs Revenue in 2023

Figure 10. Ophthalmology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Gels Picture

Figure 12. Eye Solutions Picture

Figure 13. Capsules & Tablets Picture

Figure 14. Eye Drops Picture

Figure 15. Ointments Picture

Figure 16. Global Ophthalmology Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Ophthalmology Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Ophthalmology Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Ophthalmology Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Ophthalmology Drugs Price by Type (2019-2030) & (USD/Unit)

Figure 21. Product Picture of Hospital

Figure 22. Product Picture of Retail Pharmacy

Figure 23. Global Ophthalmology Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Ophthalmology Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Ophthalmology Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Ophthalmology Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Ophthalmology Drugs Price by Application (2019-2030) & (USD/Unit)

Figure 28. North America Ophthalmology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Ophthalmology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Ophthalmology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Ophthalmology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Ophthalmology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Ophthalmology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Ophthalmology Drugs Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Ophthalmology Drugs Sales Volume (%), (2019-2030)

Figure 40. United States Ophthalmology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Ophthalmology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Ophthalmology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Ophthalmology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 46. China Ophthalmology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 48. China Ophthalmology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Ophthalmology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Ophthalmology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Ophthalmology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Ophthalmology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Ophthalmology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Ophthalmology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 58. India Ophthalmology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Ophthalmology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 60. India Ophthalmology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 61. Ophthalmology Drugs Industrial Chain

Figure 62. Ophthalmology Drugs Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Ophthalmology Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmol Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Retinal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmic Devices and Drugs Market Research Report 2025

Common Drugs Use in Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiglaucoma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Steroids Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Lasers Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Medical Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Imaging Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmology Service Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions